AM Biotechnologies DNA Sequence Analysis Solution
Based in Houston, AM Biotechnologies is focused on developing a proprietary new technology for producing chemically modified, DNA-based molecular entities called aptamers. Aptamers have uses ranging from the diagnostic quantification of a particular analyte in a blood sample to the targeted delivery of drugs to specific sites in the body. Developing these aptamers requires analyzing up to tens of billions of short DNA sequences. It uses web-based big data analysis tools from CD-HIT and Galaxy to crunch its data.